Abstract:The periostin protein, encoded by the POSTN gene, is a component of the extracellular matrix, which is expressed by fibroblasts and has been observed in a variety of human malignancies. The present study aimed to detect the expression of periostin in the tissues of non-small cell lung cancer (NSCLC) patients and benign lung tumors, and to correlate the results with the clinicopathological data of the subjects, in order to evaluate periostin as a potential prognostic marker. In total, 49 NSCLC patients and 6 benign lung tumors were included in this study. The protein level of periostin was detected in paired normal/paratumor/cancer tissues by a western blot analysis and the mRNA level in paired normal/cancer tissues was detected by quantitative polymerase chain reaction (qPCR). The results were then correlated with established biological and prognostic factors. Immunohistochemistry was used to confirm the location of periostin in the NSCLC tissues. Uni- and multivariate analyses were performed using Cox's proportional hazards regression model. The protein level of periostin was elevated in the cancer tissue of the NSCLC patients compared with the normal (P=0.017) and paratumor (P=0.000) tissues. The expression level in the male patients was much higher than in the female patients at the protein (P=0.001) and mRNA (P=0.010) levels. The mRNA level in the non-adenocarcinoma (non-ADC) patients was much higher than in the adenocarcinoma (ADC) patients (P=0.029). Periostin was demonstrated higher expression at the protein level in the pseudotumors and tuberculosis patients than in the adjacent (P=0.016) and surrounding tissues (P=0.001). Immunostaining indicated that high levels of periostin were present in the mesenchymal areas, but not in the cancer cells themselves. The patients with tumors exhibiting high-level periostin expression showed a significantly shorter survival time (P=0.036, log-rank test). The 3-year survival rate was 81.5% for patients with low-level periostin expression (periostin-L; n=27) and 45.4% for patients with high-level periostin expression (periostin-H; n=22). Similarly, pathological node (pN) status was a significant prognostic marker in the univariate Cox survival analysis. Notably, periostin-H expression was also identified as an independent prognostic factor by the multivariate analysis (P=0.011). These results showed that the overexpression of periostin predicts a poor prognosis, therefore it may be regarded as a novel molecule in the progression and development of NSCLC. The results provide an additional target for the adjuvant treatment of NSCLC.

Application of Periostin in diagnosis of colorectal cancer

Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.

Periostin As A Promising Target of Therapeutical Intervention for Colorectal Cancer

Prognostic Significance of Periostin in Colorectal Cancer.

Periostin Expression and Its Prognostic Value for Colorectal Cancer.

The Expression Analysis of Periostin in Human Breast Cancer.

Circulating Levels Of Periostin May Help Identify Patients With More Aggressive Colorectal Cancer

Periostin Identified As a Potential Biomarker of Prostate Cancer by Itraq-Proteomics Analysis of Prostate Biopsy

Expression of Periostin and Its Clinicopathological Relevance in Gastric Cancer.

Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer.

Cancer Stem Cell-Related Gene Periostin: A Novel Prognostic Marker For Breast Cancer

Correlation Between the Expression of Periostin and Epithelial-mesenchymal Transition Markers in Colorectal Cancer

Development of the periostin-ELISA kit and its preliminary clinical application

The Expression and Clinical Significance of Periostin in Human Breast Cancer

Screening of differential expression protein from human colorectal carcinoma and normal colorectal tissues by two-dimensional difference gel electrophoresis and mass spectrometry

Overexpression of Periostin Predicts Poor Prognosis in Non-Small Cell Lung Cancer.

Identification of Differentially Expressed Proteins in Colorectal Cancer by Proteomics: Down-regulation of Secretagogin

Differential Proteomics Analysis of Tumor Tissues and Their Adjacent Normal Tissues from Patients with Colorectal Cancer by Gel Electrophoresis-Capillary Liquid Chromatography-Mass Spectrometry-Based Approach

Prognostic Value of Periostin in Multiple Solid Cancers: A Systematic Review with Meta‐analysis

Research of Periostin in Cancer

Periostin, a Matrix Specific Protein, is Associated with Proliferation and Invasion of Pancreatic Cancer